Institutions to lead £1.7m-funded network to support people at risk of dementia
The neurodegenerative condition currently affects more than 944,000 people in the UK
Read More
Tag: Innovation and Involvement NETwork
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
